UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Dose Precision Using a Pretransplant Test PK of Intravenous Busulfan Prior to BuCyVP-16 Preparative Regimen in Lymphoma

Biology of blood and marrow transplantation, 2012, Vol.18 (2), p.S246-S246

2012

Volltextzugriff (PDF)

333: Preliminary Results of Phase II Trial of Clofarabine with Parenteral Busulfan Followed by Allogeneic Related or Unrelated Donor Transplantation for the Treatment of Hematologic Malignancies and Diseases

Biology of blood and marrow transplantation, 2008, Vol.14 (2), p.123-123

2008

Volltextzugriff (PDF)

Medactionplan.com As a Tool for Patient Education and Medication Management in the Blood and Marrow Transplant Setting

Biology of blood and marrow transplantation, 2009-02, Vol.15 (2), p.34-34

2009

Volltextzugriff (PDF)

Evaluating particle counters

Journal - American Water Works Association, 1997-12, Vol.89 (12), p.60-70

1997

Volltextzugriff (PDF)

High-Dose Etoposide, Cyclophosphamide, and Total Body Irradiation With Allogeneic Bone Marrow Transplantation for Patients With Acute Myeloid Leukemia in Untreated First Relapse: A Study by the North American Marrow Transplant Group

Blood, 1995-03, Vol.85 (5), p.1391-1395

1995

Volltextzugriff (PDF)

Treatment of Progressive Hodgkin’s Disease With Intensive Chemoradiotherapy and Autologous Bone Marrow Transplantation

Blood, 1989-06, Vol.73 (8), p.2086-2092

1989

Volltextzugriff (PDF)

Transfusion of donor buffy coat cells in the treatment of persistent or recurrent malignancy after allogeneic bone marrow transplantation

Transfusion (Philadelphia, Pa.), 1995-11, Vol.35 (11), p.891-898

1995

Volltextzugriff (PDF)

Hematopoietic cell transplantation (HCT) information center: A data management system and a gateway to standard statistics

Biology of blood and marrow transplantation, 2005-02, Vol.11 (2), p.108-108

2005

Volltextzugriff (PDF)

Development of nutrition algorithms for chronic GVHD

Biology of blood and marrow transplantation, 2004-02, Vol.10, p.52-53

2004

Volltextzugriff (PDF)

Results of once daily parenteral busulfan (busulfex®) with cyclophosphamide versus intermittent dosing of busulfan with cyclophosphamide as a preparative regimen for allogeneic transplant recipients with underlying hematological malignancies and diseases

Biology of blood and marrow transplantation, 2004-02, Vol.10, p.104-104

2004

Volltextzugriff (PDF)

One year results from the development and utilization of a unified strategic business plan for marketing blood and marrow transplant services’ outpatient clinic

Biology of blood and marrow transplantation, 2004-02, Vol.10, p.107-107

2004

Volltextzugriff (PDF)

Multidisciplinary approach to development of a GVHD outpatient clinic

Biology of blood and marrow transplantation, 2004-02, Vol.10, p.52-52

2004

Volltextzugriff (PDF)

Comparison of CD34+ collections in patients with multiple myeloma using etoposide/cyclophosphamide+GCSF, cyclophosphamide+GCSF, and GCSF alone mobilization regimens

Biology of blood and marrow transplantation, 2006-02, Vol.12 (2), p.121-121

2006

Volltextzugriff (PDF)

284Development and utilization of a unified strategic business plan for marketing blood and marrow transplant outpatient clinic services the goal is to increase awareness of outpatient transplants and increase referrals

Biology of blood and marrow transplantation, 2003-02, Vol.9 (2), p.145-146

2003

Volltextzugriff (PDF)

201CD34+ counts after etoposide and cyclophosphamide plus G-CSF mobilization versus G-CSF alone in multiple myeloma patients undergoing autologous transplantation

Biology of blood and marrow transplantation, 2003-02, Vol.9 (2), p.123-124

2003

Volltextzugriff (PDF)

256Utilizing a customized epidemiological, drug-susceptibility database to monitor resistance patterns and trends to make appropriate empiric antibiotic selections for blood and marrow transplant recipients

Biology of blood and marrow transplantation, 2003-02, Vol.9 (2), p.137-137

2003

Volltextzugriff (PDF)

249Changing patterns of fungal infections in a blood and marrow transplant program

Biology of blood and marrow transplantation, 2003-02, Vol.9 (2), p.135-135

2003

Volltextzugriff (PDF)

248Use of amplicor® CMV monitor(ROCHE)for CMV surveillance after blood and marrow transplantation

Biology of blood and marrow transplantation, 2003-02, Vol.9 (2), p.135-135

2003

Volltextzugriff (PDF)

250Program overview: Diseases treated, types of transplants, regimens and outcome in an outpatient blood and marrow transplant program

Biology of blood and marrow transplantation, 2003-02, Vol.9 (2), p.136-136

2003

Volltextzugriff (PDF)

Increased survival of normal cells during laser photodynamic therapy: Implications for ex vivo autologous bone marrow purging

Life sciences (1973), 1988, Vol.42 (25), p.2651-2656

1988

Volltextzugriff (PDF)

Ownship interference cancellation and source localization

IEEE Oceanic Engineering Society. OCEANS'98. Conference Proceedings (Cat. No.98CH36259), 1998, Vol.1, p.153-157 vol.1

1998

Volltextzugriff (PDF)

The effect of plasmapheresis on post-thymectomy ocular dysfunction

Canadian journal of neurological sciences, 1981-05, Vol.8 (2), p.169-172

1981

Volltextzugriff (PDF)

Formation mechanism of electrical discharge TiC-Fe composite coatings

Journal of materials processing technology, 2017-05, Vol.243, p.143-151

2017

Volltextzugriff (PDF)

1 – 25 von 124

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(105)
Mit Volltextzugriff
(111)

Publikationsform

Artikel
(120)
Tagungsberichte
(4)

Sprache

Englisch
(124)

Erscheinungsjahr

n.n

Thema

Science & Technology
(80)
Life Sciences & Biomedicine
(71)
Humans
(58)
Cardiovascular System & Cardiology
(53)
Middle Aged
(53)
Cardiac & Cardiovascular Systems
(51)
Male
(51)
Female
(49)
Prognosis
(46)
Registries
(35)
Coronary Artery Disease - Diagnostic Imaging
(32)
Coronary Angiography - Methods
(31)
Aged
(30)
Coronary Artery Disease
(29)
Risk Factors
(29)
Radiology, Nuclear Medicine & Medical Imaging
(28)
Prospective Studies
(22)
Cardiovascular
(21)
Predictive Value Of Tests
(19)
Adult
(18)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Dose Precision Using a Pretransplant Test PK of Intravenous Busulfan Prior to BuCyVP-16 Preparative Regimen in Lymphoma

333: Preliminary Results of Phase II Trial of Clofarabine with Parenteral Busulfan Followed by Allogeneic Related or Unrelated Donor Transplantation for the Treatment of Hematologic Malignancies and Diseases

Medactionplan.com As a Tool for Patient Education and Medication Management in the Blood and Marrow Transplant Setting

Evaluating particle counters

High-Dose Etoposide, Cyclophosphamide, and Total Body Irradiation With Allogeneic Bone Marrow Transplantation for Patients With Acute Myeloid Leukemia in Untreated First Relapse: A Study by the North American Marrow Transplant Group

Treatment of Progressive Hodgkin’s Disease With Intensive Chemoradiotherapy and Autologous Bone Marrow Transplantation

Transfusion of donor buffy coat cells in the treatment of persistent or recurrent malignancy after allogeneic bone marrow transplantation

Hematopoietic cell transplantation (HCT) information center: A data management system and a gateway to standard statistics

Development of nutrition algorithms for chronic GVHD

Results of once daily parenteral busulfan (busulfex®) with cyclophosphamide versus intermittent dosing of busulfan with cyclophosphamide as a preparative regimen for allogeneic transplant recipients with underlying hematological malignancies and diseases

One year results from the development and utilization of a unified strategic business plan for marketing blood and marrow transplant services’ outpatient clinic

Multidisciplinary approach to development of a GVHD outpatient clinic

Comparison of CD34+ collections in patients with multiple myeloma using etoposide/cyclophosphamide+GCSF, cyclophosphamide+GCSF, and GCSF alone mobilization regimens

284Development and utilization of a unified strategic business plan for marketing blood and marrow transplant outpatient clinic services the goal is to increase awareness of outpatient transplants and increase referrals

201CD34+ counts after etoposide and cyclophosphamide plus G-CSF mobilization versus G-CSF alone in multiple myeloma patients undergoing autologous transplantation

256Utilizing a customized epidemiological, drug-susceptibility database to monitor resistance patterns and trends to make appropriate empiric antibiotic selections for blood and marrow transplant recipients

249Changing patterns of fungal infections in a blood and marrow transplant program

248Use of amplicor® CMV monitor(ROCHE)for CMV surveillance after blood and marrow transplantation

250Program overview: Diseases treated, types of transplants, regimens and outcome in an outpatient blood and marrow transplant program

Increased survival of normal cells during laser photodynamic therapy: Implications for ex vivo autologous bone marrow purging

Ownship interference cancellation and source localization

The effect of plasmapheresis on post-thymectomy ocular dysfunction

Formation mechanism of electrical discharge TiC-Fe composite coatings

Machine learning for prediction of all-cause mortality in patients with suspected coronary artery disease: a 5-year multicentre prospective registry analysis

Coronary Computed Tomographic Angiography and Risk of All-Cause Mortality and Nonfatal Myocardial Infarction in Subjects Without Chest Pain Syndrome From the CONFIRM Registry (Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter Registry)

Suchergebnisse filtern